Crossbow Versus Forsus Springs in Mild to Moderate Class II Malocclusion Cases

计划入组 54 人 · 首次发布于 2012 年 2 月 10 日

EMDR on Pain in Patients With in Patients Rheumatoid Arthritis

计划入组 64 人 · 首次发布于 2023 年 7 月 13 日

Clinical Performance of BIS-GMA Free Dental Resin Composite

计划入组 40 人 · 首次发布于 2022 年 7 月 29 日

thalassemia therapeutics

PGTI-0306 based therapeutics (Phenogene Therapeutics)

undisclosed therapeutics

Crossbow Therapeutics, Inc.

United States

JASPER THERAPEUTICS, INC

United States

CRISPR Therapeutics, Inc.

United States

Crossbow Therapeutics Secures $77 Million Series B to Advance TCR-Mimetic Cancer Immunotherapies

Crossbow Therapeutics Doses First Patient in Phase 1 Trial of First-in-Class T-Cell Engager CBX-663

Acuitas Therapeutics Acquires Majority Stake in RNA Technologies & Therapeutics to Advance RNA-LNP Therapeutics